Patents by Inventor Anna V. Kukekova

Anna V. Kukekova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for identifying oculoskeletal dysplasia in dogs
    Patent number: 8119343
    Abstract: Provided are methods for identifying dogs as likely to be genetically normal, carriers of, or affected with Oculo-skeletal dysplasia (OSD) by determining the presence or absence of a drd2 COL9A2 mutation and/or a drd1 COL9A3 mutation. Also provided is a method for selective breeding of dogs and kits useful for carrying out the methods of the invention.
    Type: Grant
    Filed: August 27, 2008
    Date of Patent: February 21, 2012
    Assignee: Cornell University
    Inventors: Gregory M. Acland, Orly Goldstein, Anna V. Kukekova, Jennifer Lynn Johnson
  • Diagnostic test for Collie Eye Anomaly
    Patent number: 7723507
    Abstract: The invention relates to a method for identifying dogs which are genetically normal, heterozygous for, or homozygous for the mutation primarily responsible for Collie eye anomaly (CEA). The method comprises the steps of obtaining a biological sample from a dog and testing DNA in the biological sample for the presence or absence of a 7.8 kilobase deletion within chromosome 37 in which the CEA mutation is located. No deletion is indicative of a normal dog. A deletion on one allele of chromosome 37 is indicative of a dog that is heterozygous for the CEA mutation. A deletion in both alleles of chromosome 37 are indicative of a dog that is homozygous for the CEA mutation. Also provided is a kit for identifying a dog as normal, heterozygous for, or homozygous for the CEA mutation.
    Type: Grant
    Filed: September 22, 2008
    Date of Patent: May 25, 2010
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Gregory M. Acland, Anna V. Kukekova, Gustavo D. Aguirre, Elaine Ostrander, Dayna Akey, Orly Goldstein
  • DIAGNOSTIC TEST FOR COLLIE EYE ANOMALY
    Publication number: 20090176225
    Abstract: The invention relates to a method for identifying dogs which are genetically normal, heterozygous for, or homozygous for the mutation primarily responsible for Collie eye anomaly (CEA). The method comprises the steps of obtaining a biological sample from a dog and testing DNA in the biological sample for the presence or absence of a 7.8 kilobase deletion within chromosome 37 in which the CEA mutation is located. No deletion is indicative of a normal dog. A deletion on one allele of chromosome 37 is indicative of a dog that is heterozygous for the CEA mutation. A deletion in both alleles of chromosome 37 are indicative of a dog that is homozygous for the CEA mutation. Also provided is a kit for identifying a dog as normal, heterozygous for, or homozygous for the CEA mutation.
    Type: Application
    Filed: September 22, 2008
    Publication date: July 9, 2009
    Inventors: Gregory M. Acland, Anna V. Kukekova, Gustavo D. Aguirre, Elaine Ostrander, Dayna Akey, Orly Goldstein
  • METHOD FOR IDENTIFYING OCULOSKELETAL DYSPLASIA IN DOGS
    Publication number: 20090061448
    Abstract: Provided are methods for identifying dogs as likely to be genetically normal, carriers of, or affected with Oculo-skeletal dysplasia (OSD) by determining the presence or absence of a drd2 COL9A2 mutation and/or a drd1 COL9A3 mutation. Also provided is a method for selective breeding of dogs and kits useful for carrying out the methods of the invention.
    Type: Application
    Filed: August 27, 2008
    Publication date: March 5, 2009
    Applicant: Cornell Research Foundation, Inc.
    Inventors: Gregory M. Acland, Orly Goldstein, Anna V. Kukekova, Jennifer Lynn Johnson
  • Diagnostic test for collie eye anomaly
    Patent number: 7462455
    Abstract: The invention relates to a method for identifying dogs which are genetically normal, heterozygous for, or homozygous for the mutation primarily responsible for Collie eye anomaly (CEA). The method comprises the steps of obtaining a biological sample from a dog and testing DNA in the biological sample for the presence or absence of a 7.8 kilobase deletion within chromosome 37 in which the CEA mutation is located. No deletion is indicative of a normal dog. A deletion on one allele of chromosome 37 is indicative of a dog that is heterozygous for the CEA mutation. A deletion in both alleles of chromosome 37 are indicative of a dog that is homozygous for the CEA mutation. Also provided is a kit for identifying a dog as normal, heterozygous for, or homozygous for the CEA mutation.
    Type: Grant
    Filed: October 20, 2005
    Date of Patent: December 9, 2008
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Gregory M. Acland, Anna V. Kukekova, Gustavo D. Aguirre, Elaine Ostrander, Dayna Akey, Orly Goldstein